Gene · 129607
Papers1,751
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,751
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms of action of NME metastasis suppressors - a family affair. | Cancer Metastasis Rev | 2023 | 37353690 | PubTator, text mining | PubMed |
| Pregnancy-associated systemic gene expression compared to a pre-pregnancy baseline, among healthy women with term pregnancies. | Front Immunol | 2023 | 37342349 | PubTator, text mining | PubMed |
| Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis. | Front Immunol | 2023 | 37325639 | PubTator, text mining | PubMed |
| A Unique Mode of Coenzyme A Binding to the Nucleotide Binding Pocket of Human Metastasis Suppressor NME1. | Int J Mol Sci | 2023 | 37298313 | PubTator, text mining | PubMed |
| Application of novel plasma separation filter cards for quantification of nucleoside/nucleotide reverse transcriptase inhibitor di/triphosphates in dried blood spots using LC-MS. | Bioanalysis | 2023 | 37293769 | PubTator, text mining | PubMed |
| Nucleic acid biomarkers of immune response and cell and tissue damage in children with COVID-19 and MIS-C. | Cell Rep Med | 2023 | 37279751 | PubTator, text mining | PubMed |
| Cmpk2 regulates mitochondrial function in glucocorticoid-induced osteoblast senescence and affects glucocorticoid-inhibited osteoblast differentiation. | Arch Gerontol Geriatr | 2023 | 37269696 | PubTator, text mining | PubMed |
| Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection. | Immunity | 2023 | 37257450 | PubTator, text mining | PubMed |
| Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm? | Front Pharmacol | 2023 | 37256234 | PubTator, text mining | PubMed |
| Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase. | Nat Commun | 2023 | 37253718 | PubTator, text mining | PubMed |
| Brain Calcifications: Genetic, Molecular, and Clinical Aspects. | Int J Mol Sci | 2023 | 37240341 | PubTator, text mining | PubMed |
| Water mass age structures the auxiliary metabolic gene content of free-living and particle-attached deep ocean viral communities. | Microbiome | 2023 | 37237317 | PubTator, text mining | PubMed |
| Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4+ T cells. | Cell Rep | 2023 | 37227817 | PubTator, text mining | PubMed |
| Deep Proteomics Network and Machine Learning Analysis of Human Cerebrospinal Fluid in Japanese Encephalitis Virus Infection. | J Proteome Res | 2023 | 37219084 | PubTator, text mining | PubMed |
| The predictive value of prognosis and therapeutic response for STAT family in pancreatic cancer. | Heliyon | 2023 | 37215832 | PubTator, text mining | PubMed |
| Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia. | Cancer Cell Int | 2023 | 37208719 | PubTator, text mining | PubMed |
| Asymmetric presentation with a novel RP2 gene mutation in X-Linked retinitis pigmentosa: a case report. | BMC Ophthalmol | 2023 | 37198560 | PubTator, text mining | PubMed |
| Effects of Atherogenic Factors on Endothelial Cells: Bioinformatics Analysis of Differentially Expressed Genes and Signaling Pathways. | Biomedicines | 2023 | 37189834 | PubTator, text mining | PubMed |
| Discovery and Characterization of Antibody Probes of Module 2 of the 6-Deoxyerythronolide B Synthase. | Biochemistry | 2023 | 37184546 | PubTator, text mining | PubMed |
| Role of Helicobacter pylori in Gastric Carcinoma: A Review. | Cureus | 2023 | 37159779 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/129607/papers?page=10